Long-term effect of rituximab in anti-mag polyneuropathy

L Benedetti; C Briani; D Franciotta; M Carpo; Luca Padua; G Zara; R Zambello; Mp Sormani; Gl Mancardi; E Nobile Orazio; A. Schenone

Long-term effect of rituximab in anti-mag polyneuropathy

L Benedetti, C Briani, D Franciotta, M Carpo, Luca Padua, G Zara, R Zambello, Mp Sormani, Gl Mancardi, E Nobile Orazio, A. Schenone

Risultato della ricerca: Contributo in rivista › Articolo in rivista

59 Citazioni (Scopus)

Abstract

Recent studies showed that rituximab, a chimeric anti-CD20 monoclonal antibody, reduces antibody levels and ameliorates neuropathy in two thirds of patients with neuropathy and anti-myelin-associated glycoprotein (MAG) monoclonal IgM. Few data are available on the long-term effects of this therapy. We report on the long-term follow-up of rituximab responders with anti-MAG polyneuropathy.

Lingua originale	English
pagine (da-a)	1742-1744
Numero di pagine	3
Rivista	Neurology
Volume	71
Stato di pubblicazione	Pubblicato - 2008

Keywords

polyneuropathy
rituximab

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{e5fac69cdf814e9cbaa98172c4f6eed3,

title = "Long-term effect of rituximab in anti-mag polyneuropathy",

abstract = "Recent studies showed that rituximab, a chimeric anti-CD20 monoclonal antibody, reduces antibody levels and ameliorates neuropathy in two thirds of patients with neuropathy and anti-myelin-associated glycoprotein (MAG) monoclonal IgM. Few data are available on the long-term effects of this therapy. We report on the long-term follow-up of rituximab responders with anti-MAG polyneuropathy.",

keywords = "polyneuropathy, rituximab, polyneuropathy, rituximab",

author = "L Benedetti and C Briani and D Franciotta and M Carpo and Luca Padua and G Zara and R Zambello and Mp Sormani and Gl Mancardi and {Nobile Orazio}, E and A. Schenone",

year = "2008",

language = "English",

volume = "71",

pages = "1742--1744",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320",

}

TY - JOUR

T1 - Long-term effect of rituximab in anti-mag polyneuropathy

AU - Benedetti, L

AU - Briani, C

AU - Franciotta, D

AU - Carpo, M

AU - Padua, Luca

AU - Zara, G

AU - Zambello, R

AU - Sormani, Mp

AU - Mancardi, Gl

AU - Nobile Orazio, E

AU - Schenone, A.

PY - 2008

Y1 - 2008

N2 - Recent studies showed that rituximab, a chimeric anti-CD20 monoclonal antibody, reduces antibody levels and ameliorates neuropathy in two thirds of patients with neuropathy and anti-myelin-associated glycoprotein (MAG) monoclonal IgM. Few data are available on the long-term effects of this therapy. We report on the long-term follow-up of rituximab responders with anti-MAG polyneuropathy.

AB - Recent studies showed that rituximab, a chimeric anti-CD20 monoclonal antibody, reduces antibody levels and ameliorates neuropathy in two thirds of patients with neuropathy and anti-myelin-associated glycoprotein (MAG) monoclonal IgM. Few data are available on the long-term effects of this therapy. We report on the long-term follow-up of rituximab responders with anti-MAG polyneuropathy.

KW - polyneuropathy

KW - rituximab

KW - polyneuropathy

KW - rituximab

UR - http://hdl.handle.net/10807/11009

M3 - Article

SN - 0028-3878

VL - 71

SP - 1742

EP - 1744

JO - Neurology

JF - Neurology

ER -

Long-term effect of rituximab in anti-mag polyneuropathy

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo